APOE ε4 carriage associates with improved myocardial performance from adolescence to older age
Constantin‐Cristian Topriceanu(Barts Health NHS Trust), Gabriella Captur(The Royal Free Hospital), Hunain Shiwani(Barts Health NHS Trust), Jonathan M. Schott(UK Dementia Research Institute), Marcus Richards(MRC Unit for Lifelong Health and Ageing), Mit Shah(MRC London Institute of Medical Sciences), Alun D. Hughes(University of Aberdeen), Declan P. O’Regan(MRC Clinical Trials Unit at UCL), Aroon D. Hingorani(University College London), Nish Chaturvedi(University of Copenhagen), James Moon(Virginia Mason Medical Center), Matthew Webber(Wellington Hospital), Fiona Chan(MRC Unit for Lifelong Health and Ageing)
Cited by 4
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
Treatment of Periodontitis and Endothelial Function
|New England Journal of Medicine|2007|1.3k
Vascular Risk Factors and Diabetic Neuropathy
|New England Journal of Medicine|2005|1.3k
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement
|Journal of Cardiovascular Magnetic Resonance|2013|1.1k